Hi! 👋 We have a new venture. Please check out Satire Labs 😉.
The funniest way to turn your $100 to $1 million. ⛴️ 🚢.
Note: This is a joke. Kinda. We really do think you'll make money 😎🙂

What is CVS's Stock-Based Compensation (SBC)?

  CVS Health Corp ( CVS ) |
2006 - 2021 (16 years)

Stock-Based Compensation (SBC) is 
$386.9M (1Y -5.49% )

CVS Stock Price & Stock-Based Compensation (SBC)

Stock-Based Compensation (SBC) for CVS competitors.
PETS BIOS RAD WBA
Note: Stonk = Stock. Both words are used interchangeably. 🙂

Historical (All-Time) Stats for Stock-Based Compensation (SBC)

chevron_right 2021 $199.0M +10.7x
( +16.6% / year avg)
chevron_left 2006 $17.0M
vertical_align_top Peak $463.0M +18.8x *
vertical_align_bottom Bottom -$26.0M
arrow_drop_up # Up Years 10 10 of 16
years up.
arrow_drop_down # Down Years 6
Up Years = Positive (0%+) YoY change
Down Years = Zero or Negative (0% or less) YoY change

Key Points (Stonk Price Comparison)

  • CVS's stock price has rallied +43,783% from $0.13 in 2006 , or +40.8x faster than it's stock-based compensation (sbc) over the same period.
  • If CVS grows it's stock at the same rate as it's stock-based compensation (sbc) (+16.6%/year) , it's stock price will grow +464% and hit $269.27 over the next 10 years.
  • CVS's stock price has gone up 4 of the 10 years (+40%) it's stock-based compensation (sbc) were also up.
* A modified method (see: here) is used to calculate changes that involve negative numbers.
  • CVS Historical Stock-Based Compensation (SBC) Table
    in $ million
    * A modified method (see: here) is used to calculate changes that involve negative numbers.
    Year Stock-Based Compensation (SBC) YoY % Change* Stock Price YoY % Change (Stock Price)
    4/1/2021 $199 -48.4% $57.97 -10.9%
    4/1/2020 $386 -16.6% $65.06 29.2%
    4/1/2019 $463 98.7% $50.35 -14.7%
    4/1/2018 $233 1.7% $59.05 -15.2%
    4/1/2017 $229 3.6% $69.68 -18.6%
    4/1/2016 $221 0.9% $85.58 -4.4%
    4/1/2015 $219 36.0% $89.48 32.6%
    4/1/2014 $161 18.4% $67.5 38.7%
    4/1/2013 $136 3.0% $48.68 30.1%
    4/1/2012 $132 -4.3% $37.42 17.8%
    4/1/2011 $138 -16.1% $31.76 13.2%
    4/1/2010 $164 31.4% $28.06 17.3%
    4/1/2009 $125 1687.1% $23.92 -29.7%
    4/1/2008 $7 -126.9% $34.02 11.7%
    4/1/2007 $-26 -252.9% $30.45 38.9%
    4/1/2006 $17 - $21.92 -

  • About
    Industry: Health Care Plans
    Sector: Healthcare
    Country: US
    IPO Date: 10/1/1952
    Stonk Exchange: NYSE
    • CVS Health Corp
    • engages in the provision of health care services.
    • The company is headquartered in Woonsocket, Rhode Island and currently employs 295,000 full-time employees.
    • The firm provides pharmacy care for the senior community through Omnicare, Inc.
    • (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
    • The company operates through three segments: Pharmacy Services, Retail/LTC and Corporate.
    • The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients.
    • As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites, CVS.
    • com, Navarro
    • com and Onofre
    • com
    • br, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics.

  • Stock-Based Compensation (also called Share-Based Compensation or Equity Compensation) is a way of paying employees, executives, and directors of a company with shares of ownership in the business. It is typically used to motivate employees beyond their regular cash-based compensation (salary and bonus) and to align their interests with those of the company. Shares issued to employees are usually subject to a vesting period before they can be sold.

    For more detailed definitions, please see Investopedia.